Medico Remedies Limited — Important, 12-11-2024: Financial Result Updates

Medico Remedies Ltd. has announced a board meeting to review its unaudited financial results for the quarter and half-year. The company reported a total revenue of ₹3,900.25 crore, reflecting a significant year-over-year revenue increase driven primarily by strong demand in international markets.

Net profit for the period stood at ₹852.80 crore, up from ₹829.84 crore a year earlier, translating to an Earnings Per Share (EPS) of ₹0.45. This modest increase in profitability can be attributed to effective cost management despite rising operational expenses, which changed by approximately 5% as the company navigated through raw material pricing pressures and wage inflation.

The balance sheet remains robust, with total assets of ₹9,903.98 crore, bolstered by a healthy equity base of ₹5,550.83 crore. The current ratio indicates short-term liquidity, essential for ongoing operations.

Looking ahead, the strategic focus appears to be on expanding market access and optimizing supply chains. Investor sentiment remains cautiously optimistic, with a general view to hold, supported by stable financial performance and management's growth initiatives.